Molecular nociceptive mechanisms in migraine: The migraine cascade
European Journal of Neurology · 2024-08 · 31 (8)
DOI: 10.1111/ene.16333 ↗At a glance
Übersichtsarbeit in European Journal of Neurology, published online on 2024-06-18. Written by Song Guo and 3 co-authors. Institution: Danish Headache Center, Department of Neurology, Translational Research Center, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, Univ…. Major MEDLINE topics: Migraine Disorders, Pituitary Adenylate Cyclase-Activating Polypeptide, Nociception. Cited 10 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Objective
This review will explore the categorization of migraine‐provoking molecules, their cellular actions, site of action and potential drug targets based on the migraine cascade model.
Methods
Personal experience and literature.
Results
Migraine impacts over 1 billion people worldwide but is underfunded in research. Recent progress, particularly through the human and animal provocation model, has deepened our understanding of its mechanisms. This model have identified endogenous neuropeptides such as calcitonin gene‐related peptide (CGRP) and pituitary adenylate cyclase‐activating peptide (PACAP) that induces controlled migraine‐like attacks leading to significant discoveries of their role in migraine. This knowledge led to the development of CGRP‐inhibiting drugs; a groundbreaking migraine treatment now accessible globally. Also a PACAP‐inhibiting drug was effective in a recent phase II trial. Notably, rodent studies have shed light on pain pathways and the mechanisms of various migraine‐inducing substances identifying novel drug targets. This is primarily done by using selective inhibitors that target specific signaling pathways of the known migraine triggers leading to the hypothesized cellular cascade model of migraine.
Conclusion
The model of migraine presents numerous opportunities for innovative drug development. The future of new migraine treatments is limited only by the investment from pharmaceutical companies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Danish Headache Center, Department of Neurology, Translational Research Center, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.
- Department of Neurology, Zealand University Hospital, Roskilde, Denmark.
ORCID profiles: Song Guo, Jes Olesen
Cite
APA
Guo, S., Christensen, S. L., Al-Karagholi, M. A., & Olesen, J. (2024). Molecular nociceptive mechanisms in migraine: The migraine cascade. European Journal of Neurology, 31(8). https://doi.org/10.1111/ene.16333
Vancouver
Guo S, Christensen SL, Al-Karagholi MA, Olesen J. Molecular nociceptive mechanisms in migraine: The migraine cascade. European Journal of Neurology. 2024;31(8). doi:10.1111/ene.16333
BibTeX
@article{Guo2024,
author = {Guo, Song and Christensen, Sarah Louise and Al-Karagholi, Mohammad Al-Mahdi and Olesen, Jes},
title = {Molecular nociceptive mechanisms in migraine: The migraine cascade},
journal = {European Journal of Neurology},
year = {2024},
volume = {31},
number = {8},
doi = {10.1111/ene.16333}
}
EUVIMED